Werfen Completes Acquisition Of Immucor, Inc., Expanding Leadership In Specialized Diagnostics

Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion.The transaction has received all necessary regulatory approvals.The Transfusion

Related Keywords

Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Dennis Riedl ,Prnewswire Werfen ,Carlos Pascual ,Immucor Inc , ,Acute Care ,Specialized Diagnostic ,Specialized Diagnostics ,Acute Care Diagnostics ,Original Equipment Manufacturing ,Werfen ,Ompletes ,Cquisition ,Immucor ,Xpanding ,Leadership ,Specialized ,Iagnostics ,